Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Photomedics is raising $2,319,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Nikolaos Soukos played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Photomedics

Photomedics was founded to advance oral health technology, commercializing scientific breakthroughs in Dental Care pioneered at the renowned Harvard University-affiliated Forsyth Institute. The company has developed the first intra-oral light device with antibacterial action based on Forsyth’s patented Photomedicine technology. It will provide consumers with effective and economical non-invasive targeted antibacterial action to combat the most important of the dental diseases, such as gingivitis and periodontitis, as well as halitosis (bad breath).

To learn more about Photomedics, visit http://www.photomedics.com/

Contact:
Nikolaos Soukos, Chief Executive Officer
617-527-1682
https://www.linkedin.com/in/nikos-soukos-6189b96/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved